Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal. MiroBio was formed in 2019 to ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Bill covers business aviation and advanced air mobility for Aviation Week Network. A former newspaper reporter, he has also covered the airline industry, military aviation, commercial space and ...

Irene Klotz is Senior Space Editor for Aviation Week, based in Cape Canaveral. Before joining Aviation Week in 2017, Irene spent 25 years as a wire service reporter covering human and robotic ...

Biological sciences encompasses all the divisions of natural sciences examining various aspects of vital processes. The concept includes anatomy, physiology, cell biology, biochemistry and ...

CAPA publishes more than 1,000 global News Briefs every week, covering all aspects of the aviation and travel industry ... Premium CAPA Members can also access add-ons such as our exclusive Fleet ...